The Japanese robot and drives manufacturer Yaskawa has launched a pair of product families designed to enhance the safety ...

With the power of robotics and the personalized medicine expertise of one of Japan's top drugmakers, Astellas Pharma and Yaskawa Electric Corporation are setting off on a joint venture to help stre | ...

Astellas Pharma Inc. is setting up a joint venture with Yaskawa Electric Corp. to develop a new cell production platform ...

Astellas Pharma and the Yaskawa Electric Corporation have agreed to form a joint venture (JV) that will focus on developing a ...

Astellas, YASKAWA agree to establish a JV focused on cell therapy manufacturing: Tokyo Friday, March 7, 2025, 10:00 Hrs [IST] Astellas Pharma Inc. and YASKAWA Electric Corporation ...

Joint venture is expected to leverage Astellas' expertise in cell therapy R&D and Yaskawa’s robotics technology to enhance ...

The agreement—powered by YASKAWA's Maholo robot—aims to address challenges in production and commercialization while offering ...

Astellas and Yaskawa are establishing a joint venture for the development of a cell therapy product manufacturing platform ...

Astellas Pharma (OTCPK:ALPMY) and YASKAWA Electric signed a definitive agreement to establish a joint venture for the development of a cell therapy product manufacturing platform utilizing the ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and YASKAWA Electric Corporation (TSE: 6506, President and CEO; Masahiro Ogawa, "YASKAWA") signed a definitive agreement ...

Tokyo, Japan - NEPCON JAPAN 2025 concluded its successful run at Tokyo Big Sight. The event attracted a remarkable 85,430* ...

Keyence's valuation improves as automation trends grow. Learn about margin recovery, market opportunities, and why it might ...